To be awarded to an individual with an outstanding contribution to the field of haemoglobinopathies.

The University of Nicosia (UNIC) Medical School and the Thalassaemia International Federation (TIF) jointly award, on a biennial basis, the ‘Panos Englezos Prize’, to an individual who has made an outstanding contribution in one or more of the following:

  • the areas of public health relevant to haemoglobin disorders
  • the improvement of medical and other care of patients with haemoglobin disorders
  • the improvement of the quality of life of patients with haemoglobin disorders or other chronic/ genetic diseases
  • a scientific/medical advancement for the prevention and/or management of any other disease that could be applied to make a difference in the prevention and/or management or holistic care or cure of haemoglobin disorders.

Application Process

Opening date:                   1 March 2022

Closing date:                     31 March 2022

Selection Committee:  The Selection Committee comprises five members of the UNIC Medical School faculty

Award:                                   €5.000

Receipt of Award:           28 June 2022 during the UNIC Medical School Graduation Ceremony

Nomination Process

Nominations are invited by:
1. An individual (or a group) with medical/scientific/academic capacity and with an international reputation in the field in which they propose the nominee for the prize.

2. A Patient Organisation* (one or more jointly) if the nomination concerns a social contribution. If the nomination concerns an academic or a scientific achievement in collaboration with an academic department with an international reputation in the field of haemoglobin disorders.

* The Patient Organisation needs to be officially registered in the country in which it operates and an official member of TIF (General or Voting) for more than a year.

Nominations should be submitted with all supporting documents (Completed Nomination Form, Nomination Letter of Support and the Nominee CV) and sent electronically to [email protected] with a copy to [email protected].